Genetron Health Announces Pricing of Initial Public Offering Genetron Health Announces Pricing of Initial Public Offering All News, Portfolio News Genetron Health Announces Pricing of Initial Public Offering Genetron Health Announces Pricing of Initial Public Offeringartrix2020-06-20T10:42:44-07:00
IVERIC bio, Inc. Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants IVERIC bio, Inc. Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants All News, Portfolio News IVERIC bio, Inc. Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants IVERIC bio, Inc. Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrantsartrix2020-06-20T10:44:04-07:00
Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19 Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19 All News, Portfolio News Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19 Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19artrix2020-06-18T16:56:31-07:00
Legend Biotech Corporation Announces Pricing of Initial Public Offering Legend Biotech Corporation Announces Pricing of Initial Public Offering All News, Portfolio News Legend Biotech Corporation Announces Pricing of Initial Public Offering Legend Biotech Corporation Announces Pricing of Initial Public Offeringartrix2020-06-18T16:55:24-07:00
Legend Biotech Raises $150.5 Million in Series A Preferred Financing To Advance its Oncology Pipeline and Platform Legend Biotech Raises $150.5 Million in Series A Preferred Financing To Advance its Oncology Pipeline and Platform All News, Portfolio News, Vivo News Legend Biotech Raises $150.5 Million in Series A Preferred Financing To Advance its Oncology Pipeline and Platform Legend Biotech Raises $150.5 Million in Series A Preferred Financing To Advance its Oncology Pipeline and Platformartrix2020-04-21T13:06:00-07:00
RemeGen Completes USD $100 Million Plus in Funding RemeGen Completes USD $100 Million Plus in Funding All News, Portfolio News RemeGen Completes USD $100 Million Plus in Funding RemeGen Completes USD $100 Million Plus in Fundingartrix2020-04-21T13:04:42-07:00
Gilead to Acquire Forty Seven for $4.9 Billion Gilead to Acquire Forty Seven for $4.9 Billion All News, Portfolio News Gilead to Acquire Forty Seven for $4.9 Billion Gilead to Acquire Forty Seven for $4.9 Billionartrix2020-06-18T17:04:46-07:00
Passage Bio Announces Pricing of Initial Public Offering Passage Bio Announces Pricing of Initial Public Offering All News, Portfolio News Passage Bio Announces Pricing of Initial Public Offering Passage Bio Announces Pricing of Initial Public Offeringartrix2020-06-18T17:01:08-07:00
Revolution Medicines Announces Pricing of Initial Public Offering Revolution Medicines Announces Pricing of Initial Public Offering All News, Portfolio News Revolution Medicines Announces Pricing of Initial Public Offering Revolution Medicines Announces Pricing of Initial Public Offeringartrix2020-06-18T17:03:04-07:00
Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors All News, Portfolio News Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumorsartrix2019-11-13T04:26:51-08:00
